The relationship between lipids/lipoproteins and atherosclerosis in African Americans and Whites: The atherosclerosis risk in communities study

Annals of Epidemiology

Volumn 9, Issue 3, 1999, Pages 149-158

  Sorlie, Paul D ^a   Sharrett, A Richey ^a   Patsch, Wolfgang ^b   Schreiner, Pamela J ^c   Davis, Clarence E ^d   Heiss, Gerardo ^d   Hutchinson, Richard ^e  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF MINNESOTA   (United States)

^d IL   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cholesterol; Ethnic groups; Lipoproteins; Prospective studies

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CORONARY ARTERY ATHEROSCLEROSIS; DYSLIPIDEMIA; ETHNIC GROUP; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; ARTERIOSCLEROSIS; CAROTID STENOSIS; CHOLESTEROL, HDL; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 0033003284     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(98)00063-5     Document Type: Article

References (57)

1. Kannel W.B., Dawber T.R., Kagan A., Revotskie N., Stokes J. Factors of risk in the development of coronary heart disease - Six-year follow-up experience. Ann Int Med. 55:1961;33-50.
2. The Pooling Project Research Group Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events. Final report of The Pooling Project J Chron Dis. 31:1978;201-306.
3. Szatrowski T.P., Peterson A.V., Shimizu Y., Prentice R.L., Mason M.W., Fukunaga Y., Kato H. Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. J Chron Dis. 37:1984;569-584.
4. Robertson T.L., Kato H., Gordon T., Kagan A., Rhoads G.G., Land C.E., Worth R.M., Belsky J.L., Dock D.S., Miyanishi M., Kawamoto S. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California. Coronary heart disease risk factors in Japan and Hawaii Am J Cardiol. 39:1977;244-249.
5. Gordon T., Garcia-Palmieri M.R., Kagan A., Kannel W.B., Schiffman J. Differences in coronary heart disease in Framingham, Honolulu, and Puerto Rico. J Chron Dis. 27:1974;329-344.
6. Goldbourt U., Medalie J.H., Neufeld H.N. Clinical myocardial infarction over a 5-year period - III. A multivariate analysis of incidence, The Israel Ischemic Heart Disease Study. J Chron Dis. 28:1975;217-237.
7. Goldbourt U., Shlomit Y. Cholesterol and coronary heart disease mortality. Arteriosclerosis. 10:1990;512-519.
8. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High-density lipoprotein as a protective factor against coronary heart disease, The Framingham Study. Am J Med. 62:1977;707-714.
9. Centers for Disease Control and Prevention Use of Race and Ethnicity in Public Health Surveillance. MMWR. 42(RR-10):1993;1-17.
10. The ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) Study, Design and Objectives. Am J Epidemiol. 129:1989;687-702.
11. Brown S.A., Hutchinson R., Morrisett J., Boerwinkle E., Davis C.E., Gotto A.M.J., Patsch W. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected U.S. communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 13:1993;1139-1158.
12. Sidel J., Hagele E., Ziegenhorn J., Wahlenfeld A.W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 29:1983;1075-1080.
13. Nagele U., Hagele E., Sauer G., Wiedermann E., Lehmann P., Wahlefeld A.W., Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 22:1984;165-174.
14. Warnick G.R., Benderson J.M., Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantification of high-density lipoprotein cholesterol. Clin Chem. 28:1982;1379-1388.
15. Warnick G.R., Benderson J.M., Albers J.J. Quantitation of high-density lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation. Clin Chem. 28:1982;1574.
16. Patsch W., Brown S.A., Morrisett J.D., Gotto A.M.J., Patsch J.R. A dual precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma. Clin Chem. 35:1989;265-270.
17. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
18. Schonfeld G., Pfleger B. The structure of human high-density lipoproteins and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay. J Clin Invest. 54:1974;236-246.
19. Maciejko J.J., Mao S.J.T. Radioimmunoassay of apolipoprotein A-I. Application of nonionic detergent (Tween-20) and solid-phase staphylococcus Clin Chem. 28:1982;199-204.
20. Schonfeld G., Lees R., George P.K., Pfleger B. Assay of total plasma apolipoprotein B concentration in human subjects. J Clin Invest. 53:1974;1458-1467.
21. Brown S.A., Rhodes C.E., Dunn K., Gotto A.M.J., Patsch W. Effect of blood collection and processing on radioimmunoassay results for apolipoprotein A-I in plasma. Clin Chem. 34:1988;920-924.
22. Patsch J., Patsch W. Zonal ultracentrifugation. Methods Enzymol. 129:1986;3-26.
23. Brown S.A., Epps D.F., Dunn J.K., Sharrett A.R., Patsch J.R., Gotto A.M.J., Patsch W. Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. Clin Chem. 36:1990;1662-1666.
24. Gaubatz J.W., Chari M.V., Nava M.L., Guyton J.R., Morrisett J.D. Isolation and characterization of the two major apoproteins in human lipoprotein(a). J Lipid Res. 28:1987;69-79.
25. Chambless L.E., McMahon R.P., Brown S.A., Patsch W., Heiss G., Shen Y. Short-term intraindividual variability in lipoprotein measurements. The Atherosclerosis Risk in Communities (ARIC) Study Am J Epidemiol. 136:1992;1069-1081.
26. Hutchinson R.G., Watson R.L., Davis C.E., Barnes R., Brown S., Romm F., Spencer J.M., Tyroler H.A., Wu K. Racial differences in risk factors for atherosclerosis, The ARIC Study. Angiology. 48:1997;279-290.
27. Heiss G., Sharrett A.R., Barnes R., Chambless L.E., Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations. Associations with cardiovascular risk factors in the ARIC Study Am J Epidemiol. 134:1991;250-256.
28. Dempster A.P., Laird N.M., Rubin D.B. Maximum likelihood estimation from incomplete data via the EM algorithm. J R Statis Soc. B39:1977;1-38.
29. SAS Institute Inc. SAS/STAT User's Guide, Version 6, 4th ed. Cary, NC: SAS Institute Inc. 1989:1-943.
30. Chambless L.E., Zhong M.M., Arnett D., Folsom A.R., Riley W.A., Heiss G. Variability in B-mode ultrasound measurements in the Atherosclerosis Risk in Communities (ARIC) Study. Ultrasound Med Biol. 22:1996;545-554.
31. Howard G., Sharrett A.R., Heiss G., Evans G.W., Chambless L.E., Riley W.A., Burke G.L. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke. 24:1993;1297-1304.
32. Burke G.L., Evans G.W., Riley W.A., Sharrett A.R., Howard G., Barnes R.W., Rosamond W., Crow R.S., Rautaharju P.M., Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 26:1995;386-391.
33. Chambless L.E., Heiss G., Folsom A.R., Rosamond W., Szklo M., Sharrett A.R., Clegg L. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors. The Atherosclerosis Risk in Communities (ARIC) Study 1987-1993 Am J Epidemiol. 146:1997;483-494.
34. Tyroler H.A., Knowles M.G., Wing S.B., Logue E.E., Davis C.E., Heiss G., Heyden S., Hames C.G. Ischemic heart disease risk factors and 20-year mortality in middle-age Evans County black males. Am Heart J. 108:1984;738-746.
35. Johnson J.L., Heineman E.F., Heiss G., Hames C.G., Tyroler H.A. Cardiovascular disease risk factors and mortality among black women and white women age 40-64 years in Evans County, Georgia. Am J Epidemiol. 123:1986;209-220.
36. White A.D., Hames C.G., Tyroler H.A. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study. Ann Epidemiol. 2:1992;85-91.
37. Keil J.E., Sutherland S.E., Knapp R.G., Lackland D.T., Gazes P.C., Tyroler H.A. Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med. 329:1993;73-78.
38. Keil J.E., Sutherland S.E., Knapp R.G., Gazes P.C. Serum cholesterol - Risk factor for coronary disease mortality in younger and older blacks and whites; The Charleston Heart Study, 1960-1988. Ann Epidemiol. 2:1992;93-99.
39. Keil J.E., Sutherland S.E., Hames C.G., Lackland D.T., Gazes P.C., Knapp R.G., Tyroler H.A. Coronary disease mortality and risk factors in black and white men; Results from the combined Charleston, SC, and Evans County, Georgia, Heart Studies. Arch Intern Med. 155:1995;1521-1527.
40. Cooper R.S., Ford E. Comparability of risk factors for coronary heart disease among blacks and whites in the NHANES-I Epidemiologic Follow-up Study. Ann Epidemiol. 2:1992;637-645.
41. Otten M.W., Teutsch S.M., Williamson D.F., Marks J.S. The effect of known risk factors on the excess mortality of black adults in the United States. JAMA. 263:1990;845-850.
42. Feldman J.J., Makuc D.M., Kleinman J.C., Cornoni-Huntley J. National trends in educational differentials in mortality. Am J Epidemiol. 129:1989;919-933.
43. Neaton J.D., Kuller L.H., Wentworth D., Borhani N.O. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for 5 years. Am Heart J. 108:1984;759-769.
44. Iso H., Jacobs D.R., Wentworth D., Neaton J.D., Cohen J.D. Serum cholesterol levels and 6-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 320:1989;904-910.
45. Keys A. Seven Countries, A Multivariate Analysis of Death and Coronary Heart Disease. 1980;Harvard University Press, Cambridge.
46. Kozarevic D., Pirc B., Racic Z., Dawber T.R., Gordon T., Zukel W.J. The Yugoslavia Cardiovascular Disease Study II. Factors in the incidence of coronary heart disease. Am J Epidemiol. 104:1976;133-140.
47. White A.D., Folsom A.R., Chambless L.E., Sharrett A.R., Yang K., Conwill D., Higgins M., Williams O.D., Tyroler H.A. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study. Methods and initial 2 years' experience J Clin Epidemiol. 49:1996;223-233.
48. Schreiner P.J., Heiss G., Tyroler H.A., Morrisett J.D., Davis C.E., Smith R. Race and gender differences in the association of Lp(a) with carotid artery wall thickness; The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 16:1996;471-478.
49. Steinberg S., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med. 320:1989;915-924.
50. Tell G.S., Evans G.W., Folsom A.R., Shimakawa T., Carpenter M.A., Heiss G. Dietary fat intake and carotid artery wall thickness. The ARIC Study Am J Epidemiol. 139:1994;979-989.
51. Shimakawa T., Sorlie P., Carpenter M.A., Dennis B., Tell G.S., Watson T., Williams O.D. Dietary intake patterns and sociodemographic factors in the Atherosclerosis Risk in Communities Study. Prev Med. 23:1994;769-780.
52. Kritchevsky S.B., Shimakawa T., Tell G.S., Dennis B., Carpenter M.A., Eckfeldt J.H., Peacher-Ryan H., Heiss G. Dietary antioxidants and carotid artery wall thickness. The ARIC Study Circulation. 92:1995;2142-2150.
53. Iribarren C., Folsom A.R., Jacobs D.R., Gross M.D., Belcher J.D., Eckfeldt J.H. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study Arterio Thromb Vasc Biol. 17:1997;1171-1177.
54. Demirovic J., Nabulsi A., Folsom A.R., Carpenter M.A., Szklo M., Sorlie P.D., Barnes R.W. Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility. Circulation. 88:1993;2787-2793.
55. Folsom A.R., Eckfeldt J.H., Weitzman S., Ma J., Chambless L.E., Barnes R.W., Cram K.B., Hutchinson R.G. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 25:1994;66-73.
56. Anderson K.M., Castelli W.P., Levy D. Cholesterol and mortality. Thirty years of follow-up from the Framingham Study. JAMA. 257:1987;2176-2180.
57. Diez-Roux A.V., Nieto F.J., Tyroler H.A., Crum L.D., Szklo M. Social inequalities and atherosclerosis. The Atherosclerosis Risk in Communities Study Am J Epidemiol. 141:1995;960-972.